CADL·137404109·US·equity·Healthcare - Biotechnology-Activist
CADL (CANDEL THERAPEUTICS INC) is held by 71 institutional investors as of Q1 2026. Largest holders: FMR LLC ($53.8M), RTW INVESTMENTS, LP ($31.5M), BlackRock, Inc. ($15.2M). Net institutional sentiment: Mixed.
See how CADL's score breaks down across 4 SEC sources
Showing 1-20 of 77
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer